Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus

The lack of a licensed vaccine for respiratory syncytial virus (RSV) can be partly attributed to regulatory hurdles resulting from vaccine enhanced respiratory disease (ERD) subsequent to natural RSV infection that was observed in clinical trials of formalin-inactivated RSV (FI-RSV) in antigen-naïve...

Descripción completa

Detalles Bibliográficos
Autores principales: Killikelly, April M., Kanekiyo, Masaru, Graham, Barney S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040956/
https://www.ncbi.nlm.nih.gov/pubmed/27682426
http://dx.doi.org/10.1038/srep34108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040956/
https://www.ncbi.nlm.nih.gov/pubmed/27682426
http://dx.doi.org/10.1038/srep34108

Ejemplares similares